MedTrace Logo

Flow CAST® Peanut Trial

NCT07775430 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 245

Last updated 2026-08-20

No results posted yet for this study

Summary

This will be a multi-center, prospective evaluation, conducted at a minimum of four (4) U.S. sites. Sites will enroll peanut allergic subjects, subjects with allergies other than peanut and apparently healthy non-atopic control subjects and collect blood samples for testing using Flow CAST® and the comparative ImmunoCAP sIgE test.

Conditions

  • Peanut Allergies

Interventions

DIAGNOSTIC_TEST

Basophil activation test

Flow CAST® is a flow cytometry-based basophil activation test. Whole blood samples from patients are stimulated with specific allergens, as well as stimulation buffer and stimulation controls, to evaluate the patient's basophil degranulation in vitro

Sponsors & Collaborators

  • Bühlmann Laboratories AG

    lead INDUSTRY

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2027-10-01
Completion
2027-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07775430 on ClinicalTrials.gov